Acute Porphyria Drug Database

Monograph

B03XA02 - Darbepoetin Alfa
Not porphyrinogenic
NP

Rationale
Glycoprotein hormone administered in ug dose. No CYP-interactions recognised..
Chemical description
Human erythropoietin with longer half time in the circulation than recombinant hormone, due to higher carbohydrate contents. Parenterally administered in ug quantities in anemia secondary to chronic renal insufficiency.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes B03X / B03XA or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Aranesp Aranesp Aranesp Aranesp Aranesp Aranesp ยท Aranesp SureClick Aranesp Aranesp Aranesp Aranesp Aranesp Aranesp Aranesp Aranesp
 
© NAPOS 2025
An unhandled error has occurred. Reload ๐Ÿ—™